A clearly labeled serum alternative with a hydration focus. Interpret the study methods and selected bottle size before comparing it with richer creams or more expensive serums.
- Format
- Serum
- Confirmed selection
- 50 mL; $53.82 promotion / $69 reference (November 10)
- Study context
- Manufacturer reports; no comparative testing by this publication
A serum alongside the cream shortlist
Biossance’s Squalane + Copper Peptide Rapid Plumping Serum is included as a serum, not relabeled as a cream. The official formula lists Copper Tripeptide-1 alongside squalane, glycerin, sodium hyaluronate, ectoin and other ingredients. A reader is comparing a complete hydrating formula rather than copper peptide in isolation.[source] Copper PCA is a separate declared entry.[source] The two names should not be collapsed into one concentration; neither supplies a measured amount.
That matters for expectations. A smoother or plumper appearance after moisturizing does not, by itself, demonstrate a long-term structural change. AAD guidance describes how moisturization can make some fine lines less noticeable. We keep that cosmetic effect separate from broader collagen-related marketing.[source]
Read the method beside the percentage
Each manufacturer footnote describes 31 women aged 30–65 over 28 days, with twice-daily use. The consumer footnote accompanies immediate hydration and one-week firmness headlines; the clinical footnote concerns four-week line appearance.[source] The same participant count does not establish that these were the same participants. A participant noticing firmness and a clinical assessment of line appearance are not the same measurement, even when both appear in a “results” section.
Those summaries do not establish a head-to-head advantage over CoreAge Rx Bounce Back, NIOD or another copper product. Nor do they isolate the contribution of the peptide from the rest of the formula. We have not inspected participant-level data or conducted our own product test.
The one-week headline sits beside a 28-day consumer footnote.[source] That leaves the assessment timing insufficiently explained. We did not obtain a full protocol, comparator, blinding procedure, instrumentation, statistical analysis or raw data. The word “clinical” does not supply those methods. A percentage of participants meeting an endpoint would also differ from the size of their improvement.
Price the selected size
November 10 static US page: 50 mL at $53.82 promotional price, against a $69 reference.[source] The site also lists an 80 mL jumbo size, whose price should be checked separately. Dividing each bottle price by 50 gives about $1.08 promotional or $1.38 reference per mL. This is price arithmetic only; it measures neither the amount of copper nor effectiveness. No purchase was selected and no checkout or stock allocation was tested.
Record a promotion or subscription separately from the ordinary selected-size price. A serum also need not replace the moisturizer someone already uses, so consider the full routine before deciding that the larger bottle alone makes the purchase economical.
A useful comparison for a hydration-led goal
Biossance belongs in this directory because its formula, dated offer and study notes can be examined directly. The blue color is not a potency assay, and we do not assign a peptide concentration that the page does not establish. Read the product review for the ingredient-level questions.
Your questions, answered
Does the manufacturer study show copper caused the result?
No component-isolating comparison was obtained. A result for a multi-ingredient preparation does not identify which ingredient contributed or demonstrate an advantage over a competing cream.
Does a high participant-response percentage mean a large improvement?
Those are different quantities. The proportion reporting or meeting an endpoint does not state how much the average person changed. Read the endpoint and method before treating a percentage as an effect size.
Manufacturer formula, study summaries and US offer: static page checked 2026-11-10. AAD context remains 2026-10-10; the older manufacturer record remains historical. Full study methods, independent replication, selected checkout and stock were not verified. Other retailers and individual outcomes were not assessed.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Formula and study notesChecked November 10, 2026
- AAD: wrinkle remediesOfficial guidance rechecked October 10, 2026. · Checked October 10, 2026